Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 306

1.

Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.

Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S.

Asia Pac J Clin Nutr. 2012;21(4):511-8.

PMID:
23017309
[PubMed - indexed for MEDLINE]
Free Article
2.

Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome.

Rafraf M, Mohammadi E, Asghari-Jafarabadi M, Farzadi L.

J Am Coll Nutr. 2012 Oct;31(5):361-8.

PMID:
23529993
[PubMed - indexed for MEDLINE]
3.

Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.

Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F.

J Am Coll Nutr. 2012 Apr;31(2):117-25.

PMID:
22855917
[PubMed - indexed for MEDLINE]
4.

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.

Verit FF.

Arch Gynecol Obstet. 2010 Jun;281(6):1009-14. doi: 10.1007/s00404-009-1226-6. Epub 2009 Sep 22.

PMID:
19771438
[PubMed - indexed for MEDLINE]
5.

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.

Holte J, Bergh T, Berne C, Lithell H.

Clin Endocrinol (Oxf). 1994 Oct;41(4):463-71.

PMID:
7955457
[PubMed - indexed for MEDLINE]
6.

Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome.

Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE.

Metabolism. 2011 Dec;60(12):1711-8. doi: 10.1016/j.metabol.2011.04.007. Epub 2011 Jun 2.

PMID:
21640360
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.

Kooshki A, Taleban FA, Tabibi H, Hedayati M.

Ren Fail. 2011;33(9):892-8. doi: 10.3109/0886022X.2011.605536. Epub 2011 Aug 23.

PMID:
21859401
[PubMed - indexed for MEDLINE]
8.

Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.

Koh KK, Quon MJ, Shin KC, Lim S, Lee Y, Sakuma I, Lee K, Han SH, Shin EK.

Atherosclerosis. 2012 Feb;220(2):537-44. doi: 10.1016/j.atherosclerosis.2011.11.018. Epub 2011 Nov 19.

PMID:
22153696
[PubMed - indexed for MEDLINE]
9.

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.

Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.

Gynecol Endocrinol. 2010 Mar;26(3):161-6. doi: 10.3109/09513590903247816.

PMID:
20148738
[PubMed - indexed for MEDLINE]
10.

Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.

Puurunen J, Piltonen T, Puukka K, Ruokonen A, Savolainen MJ, Bloigu R, Morin-Papunen L, Tapanainen JS.

J Clin Endocrinol Metab. 2013 Dec;98(12):4798-807. doi: 10.1210/jc.2013-2674. Epub 2013 Oct 23.

PMID:
24152688
[PubMed - indexed for MEDLINE]
11.

Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.

Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SM, Farhoudi F, Hosseininezhad SJ, Tavallaei S, Vejdani A, Azimi-Nezhad M, Shakeri MT, Rad MA, Mobarra N, Kazemi-Bajestani SM, Ferns GA.

Acta Cardiol. 2009 Jun;64(3):321-7.

PMID:
19593941
[PubMed - indexed for MEDLINE]
12.

The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: a randomized controlled clinical trial.

Fakhrzadeh H, Ghaderpanahi M, Sharifi F, Mirarefin M, Badamchizade Z, Kamrani AA, Larijani B.

Int J Vitam Nutr Res. 2010 Apr;80(2):107-16. doi: 10.1024/0300-9831/a000011.

PMID:
20803425
[PubMed - indexed for MEDLINE]
13.

[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].

Li X, Lin JF.

Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71. Chinese.

PMID:
16409817
[PubMed - indexed for MEDLINE]
14.

[Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].

Yang XF, Ren FR, Guo SP.

Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):261-3. Chinese.

PMID:
16759463
[PubMed - indexed for MEDLINE]
15.

Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.

Cussons AJ, Watts GF, Mori TA, Stuckey BG.

J Clin Endocrinol Metab. 2009 Oct;94(10):3842-8. doi: 10.1210/jc.2009-0870. Epub 2009 Jul 21.

PMID:
19622617
[PubMed - indexed for MEDLINE]
16.

Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients.

Shidfar F, Keshavarz A, Hosseyni S, Ameri A, Yarahmadi S.

East Mediterr Health J. 2008 Mar-Apr;14(2):305-13.

PMID:
18561722
[PubMed - indexed for MEDLINE]
17.

Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.

Moradi S, Mollabashi M, Kerman SR.

Gynecol Endocrinol. 2011 Jul;27(7):480-5. doi: 10.3109/09513590.2010.501876. Epub 2010 Sep 14.

PMID:
20836727
[PubMed - indexed for MEDLINE]
18.

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.

Sepilian V, Nagamani M.

J Soc Gynecol Investig. 2005 Feb;12(2):129-34.

PMID:
15695109
[PubMed - indexed for MEDLINE]
19.

Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.

Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D.

Diabetes Care. 1994 Jan;17(1):37-44.

PMID:
8112187
[PubMed - indexed for MEDLINE]
20.

Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.

Rajkhowa M, Neary RH, Kumpatla P, Game FL, Jones PW, Obhrai MS, Clayton RN.

J Clin Endocrinol Metab. 1997 Oct;82(10):3389-94.

PMID:
9329374
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk